Ticker ANVS – Annovis Bio – sales, description, marketcap – Tickerday.com

ANVS

Annovis Bio

Index: NYSE; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 37.49M; Volume: 65.73K; AvgVol 3m: 832.69K; Beta: ;

Cost estimate:

P/E: ; EPS: -0.23; EPS growth quarter/prev quarter: -478.90%;

EPS growth this year: -20.20%; EPS growth past 5 years: ;

EPS ttm: -0.51;

P/S: ; P/B: 3.55; P/Cashflow: 3.48; P/FCF: ;

Sales: ; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -55.40%; ROE – return on equity: -396.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 20.20%; Insider Transactions:0.00%;

Institutional Ownership: 11.10%; Institutional Transactions: 7.08%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *